Hi Barry81,
Yes I'm aware of Novaphos being able to produce SPA and that they have a processing facility in Florida. As I understand it commercialisation of this process by Novaphos was underway in 2019. On their website they state "we have now demonstrated that Novaphos technology is commercially viable."
How long now has Avenira had the exclusive rights to this technology? I think it's well over 2 years. Please correct me if I'm wrong. As I've acknowledged before, this combining of Avenira and Novaphos is a real plus.
I fully agree with you regarding potential, that's why I'm here and that's why I want the company to actual deliver this time on their scoping study because I think it will be a huge catalyst for the share price.
GL to us all.
Chart, page-71
Add AEV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.09M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.6¢ | 0.5¢ | $611 | 121.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 6023065 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 1598140 | 4 |
View Market Depth
| Last trade - 16.10pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.6¢ |
Change
0.000 ( 20.0 %) |
||||
| Open | High | Low | Volume | ||
| 0.6¢ | 0.6¢ | 0.5¢ | 96920 | ||
| Last updated 15.59pm 29/05/2024 ? | |||||
| AEV (ASX) Chart |